CAS 1788044-13-2: 5-Methyl-3-pyridazinemethanol
Formula:C6H8N2O
InChI:InChI=1S/C6H8N2O/c1-5-2-6(4-9)8-7-3-5/h2-3,9H,4H2,1H3
InChI key:InChIKey=IQCGESDHTKTANN-UHFFFAOYSA-N
SMILES:OCC1=NN=CC(=C1)C
- Synonyms:
- 3-Pyridazinemethanol, 5-methyl-
- 5-Methyl-3-pyridazinemethanol
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-Pyridazinemethanol, 5-methyl- REF: IN-DA0026DICAS: 1788044-13-2 | 97% | 117.00 €~304.00 € | Mon 10 Mar 25 |
 | (5-Methylpyridazin-3-yl)methanol REF: 54-OR304392CAS: 1788044-13-2 | - - - | 151.00 €~709.00 € | Mon 17 Mar 25 |
 | (5-METHYLPYRIDAZIN-3-YL)METHANOL REF: 10-F500696CAS: 1788044-13-2 | 97.0% | To inquire | Thu 20 Mar 25 |
 | (5-Methylpyridazin-3-yl)methanol REF: 3D-NWC04413CAS: 1788044-13-2 | Min. 95% | - - - | Discontinued product |
3-Pyridazinemethanol, 5-methyl-
CAS:1788044-13-2
Formula:
C6H8N2O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
124.1405
Ref: IN-DA0026DI
| 100mg | 117.00 € | ||
| 250mg | 171.00 € | ||
| 500mg | 204.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
Ref: 54-OR304392
| 1g | 692.00 € | ||
| 100mg | 151.00 € | ||
| 250mg | 265.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
(5-METHYLPYRIDAZIN-3-YL)METHANOL
CAS:1788044-13-2
Purity:
97.0%
Color and Shape:
Liquid, No data available.
Molecular weight:
124.14299774169922
Ref: 10-F500696
| 1g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 20 Mar 2025
(5-Methylpyridazin-3-yl)methanol
CAS:1788044-13-2
Please enquire for more information about (5-Methylpyridazin-3-yl)methanol including the price, delivery time and more detailed …
Formula:
C6H8N2O
Purity:
Min. 95%
Molecular weight:
124.14 g/mol
Ref: 3D-NWC04413
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
